Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RACING: Rosuvastatin Monotherapy vs. Combination with Ezetimibe in ASCVD
NCT03044665Phase 4Unknown
- Sponsor
- Yonsei University
- Start
- Mar 2017
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ezetimibe in atherosclerotic cardiovascular disease (ASCVD), sponsored by Yonsei University. Status: unknown.
02
Drugs
ezetimibe
03
Conditions
atherosclerotic cardiovascular disease (ASCVD)
Beyond the preview
Go deeper on NCT03044665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03044665.